Analysts Set Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Price Target at $54.33
Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Get Free Report) have received a consensus rating of “Buy” from the nine brokerages that are covering the firm, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year target […]
Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Get Free Report) have received a consensus rating of “Buy” from the nine brokerages that are covering the firm, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year target […]
